You have Guest access.
Log In
Published in partnership with the
European Association for the Study of Diabetes
Editorial
U. Smith and E. A. M. Gale
Journal Article
Diabetes treatment with insulin glargine and risk of malignancy: methodological pitfalls and ethical issues
D. Simon
Diabetologia, 2010, Volume 53, Number 1, Pages 204-205
Book Chapter
Developing Criteria for Defining Type 2 Diabetes in Pregnancy
Lois Jovanovic and Seanna Martin
Contemporary Endocrinology, 2008, Type 2 Diabetes Mellitus, Pages 365-375
Nice insulins, pity about the evidence
F. Holleman and E. A. M. Gale
Diabetologia, 2007, Volume 50, Number 9, Pages 1783-1790
Glucose Metabolism Disorders and the Risk of Cancer
Paweł Piątkiewicz and Anna Czech
Archivum Immunologiae et Therapiae Experimentalis, 2011, Volume 59, Number 3, Pages 215-230
Insulin and New Insulin Analogues with Focus on Type 2 Diabetes
Sten Madsbad
2007, Pharmacotherapy of Diabetes: New Developments, 2, Pages 53-65
Insulin analogs and pregnancy: an update
Elisabetta Torlone, Graziano Di Cianni, Domenico Mannino and Annunziata Lapolla
Acta Diabetologica, 2009, Volume 46, Number 3, Pages 163-172
Insulin resistance and increased risk for malignant neoplasms: confounding of the data on insulin glargine
J. M. Nagel, U. Mansmann, K. Wegscheider and J. Röhmel
Diabetologia, 2010, Volume 53, Number 1, Pages 206-208
Improving patient acceptance and adherence in diabetes management: a focus on insulin therapy
Robert E. Rakel
Advances in Therapy, 2009, Volume 26, Number 9, Pages 838-846
Insulin, Insulin Resistance, Obesity, and Cancer
Emily Jane Gallagher and Derek LeRoith
Current Diabetes Reports, 2010, Volume 10, Number 2, Pages 93-100
The treat-to-target A1C approach to control type 2 diabetes and prevent complications
Russell D. White
Advances in Therapy, 2007, Volume 24, Number 3, Pages 545-559
Keywords Cancer - Insulin analogues - Insulin therapy - Metformin - Type 2 diabetes
Frequently asked questions General info on journals and books Send us your feedback Impressum Contact us
© Springer, Part of Springer Science+Business Media Privacy, Disclaimer, Terms & Conditions, and Copyright Info